Effect of malaria parasitaemia on antibody responses to single-dose and two-dose HPV vaccination: results from the DoRIS dose-reduction immunogenicity trial in Tanzanian girls.

Saved in:
Bibliographic Details
Title: Effect of malaria parasitaemia on antibody responses to single-dose and two-dose HPV vaccination: results from the DoRIS dose-reduction immunogenicity trial in Tanzanian girls.
Authors: Whitworth HS; Clinical Research Department, London School of Hygiene and Tropical Medicine, Keppel Street, London, UK; Mwanza Intervention Trials Unit, National Institute for Medical Research, Mwanza, Tanzania., Beshir KB; Department of Infection Biology, London School of Hygiene and Tropical Medicine, Keppel Street, London, UK., Baisley KJ; International Statistics and Epidemiology Group, Department of Infectious Disease Epidemiology, London School of Hygiene and Tropical Medicine, Keppel Street, London, UK., Mbwanji G; Mwanza Intervention Trials Unit, National Institute for Medical Research, Mwanza, Tanzania., Indangasi J; Clinical Research Department, London School of Hygiene and Tropical Medicine, Keppel Street, London, UK; Mwanza Intervention Trials Unit, National Institute for Medical Research, Mwanza, Tanzania., Kemp T; HPV Immunology Laboratory, Leidos Biomedical Research Inc, Frederick National Laboratory, Frederick, MD, USA., Kamala B; Mwanza Intervention Trials Unit, National Institute for Medical Research, Mwanza, Tanzania., Maxwell C; Clinical Research Department, London School of Hygiene and Tropical Medicine, Keppel Street, London, UK; Mwanza Intervention Trials Unit, National Institute for Medical Research, Mwanza, Tanzania., Hashim R; Mwanza Intervention Trials Unit, National Institute for Medical Research, Mwanza, Tanzania., Mukerebe C; National Institute for Medical Research, Mwanza, Tanzania., Mayaud P; Clinical Research Department, London School of Hygiene and Tropical Medicine, Keppel Street, London, UK., Lowe B; Clinical Research Department, London School of Hygiene and Tropical Medicine, Keppel Street, London, UK., Gabriel N; Mwanza Intervention Trials Unit, National Institute for Medical Research, Mwanza, Tanzania., Connor N; Clinical Research Department, London School of Hygiene and Tropical Medicine, Keppel Street, London, UK., Kapiga S; Mwanza Intervention Trials Unit, National Institute for Medical Research, Mwanza, Tanzania; International Statistics and Epidemiology Group, Department of Infectious Disease Epidemiology, London School of Hygiene and Tropical Medicine, Keppel Street, London, UK., De Sanjose S; ISGlobal, Barcelona, Spain., Lacey CJ; York Biomedical Research Institute, Hull York Medical School, University of York, UK., Hayes RJ; International Statistics and Epidemiology Group, Department of Infectious Disease Epidemiology, London School of Hygiene and Tropical Medicine, Keppel Street, London, UK., Pinto L; HPV Immunology Laboratory, Leidos Biomedical Research Inc, Frederick National Laboratory, Frederick, MD, USA., Changalucha J; Mwanza Intervention Trials Unit, National Institute for Medical Research, Mwanza, Tanzania; National Institute for Medical Research, Mwanza, Tanzania., Sutherland CJ; Department of Infection Biology, London School of Hygiene and Tropical Medicine, Keppel Street, London, UK., Watson-Jones D; Clinical Research Department, London School of Hygiene and Tropical Medicine, Keppel Street, London, UK; Mwanza Intervention Trials Unit, National Institute for Medical Research, Mwanza, Tanzania. Electronic address: deborah.watson-jones@lshtm.ac.uk.
Source: Vaccine [Vaccine] 2026 Jun 30; Vol. 89, pp. 128889. Date of Electronic Publication: 2026 Jun 30.
Publication Type: Journal Article
Journal Info: Publisher: Elsevier Science Country of Publication: Netherlands NLM ID: 8406899 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1873-2518 (Electronic) Linking ISSN: 0264410X NLM ISO Abbreviation: Vaccine Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1873-2518
DOI:10.1016/j.vaccine.2026.128889